NDC00006-5055-06: MOLNUPIRAVIR CAPSULES.
The MOLNUPIRAVIR CAPSULES is a the manufacturer industrial component. Key specifications include unit_of_issue_cube: 0.0046 CUBIC FEET, unpackaged_unit_weight: 0.1433 POUNDS LBS, part_name_assigned_by_controlling_agency: MOLNUPIRAVIR CAPSULES, 200MG, 40S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-714-9242, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| unit_of_issue_cube | 0.0046 CUBIC FEET |
| unpackaged_unit_weight | 0.1433 POUNDS LBS |
| part_name_assigned_by_controlling_agency | MOLNUPIRAVIR CAPSULES, 200MG, 40S |
| NSN | 6505-01-714-9242 |
| UNIT OF ISSUE CUBE | 0.0046 CUBIC FEET |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT COVID; MECHANISM OF ACTION: INHIBITS REPLICATION BY VIRAL MUTAGENESIS FOR THE TREATMENT OF MILD TO MODERATE CORONAVIRUS DISEASE WHO ARE AT A HIGH RISK FOR PROGRESSION TO SEVERE COVID; PACKAGED AS 200 MG CAPSULES; INTENDED FOR ORAL ADMINISTRATION; 40 CAPSULES PER BOTTLE; STORE AT 20C TO 25C(68F TO 77F); EXCURSIONS PERMITTED BETWEEN 15C TO 30C(59F TO 86F)(SEE USP CONTROLLED ROOM TEMPERATURE); FOR USE UNDER EMERGENCY USE AUTHORIZATION(EUA); SHELF LIFE: 24 MONTHS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MOLNUPIRAVIR CAPSULES, 200MG, 40S |
| UNPACKAGED UNIT WEIGHT | 0.1433 POUNDS LBS |